Tag:
Corey Goodman
Latest Headlines
Latest Headlines
Corey Goodman's upstart biotech garners a $5M Series A
Corey Goodman's fledgling microbiome biotech, Second Genome, has raised $5 million in a small but tidy A round that brought in two new investors. Advanced Technology Ventures and Morgenthaler
New biotech venture firm targets private/public deals
A group of biotech veterans which includes the prolific Corey Goodman (pictured) has come together to launch a new life sciences venture firm dubbed VenBio . And they're not planning to stick with
Limerick lands $15M in Series C
With the help of new investor OVP Venture Partners South San Francisco's Limerick BioPharma has rounded up $15 million in Seriec C funding. Previous investors ARCH Venture Partners, Sevin Rosen Funds
Promising stem cell start-ups merge, add $11.5M
Two stem cell technology start-ups have agreed to merge, snagging an additional $11.5 million in fresh venture funds in the process. Pierian and iZumi Bio will create iPierian, which will be helmed
Evotec shutters Renovis in cost-cutting move
Slightly less than a year after plunking down $152 million in stock to buy South San Francisco-based Renovis, Evotec is shuttering the developer and laying off 45 staffers. The move is part of the
Pfizer's biotech leader makes an unexplained exit
Corey Goodman had been Pfizer's go-to guy for biotechnology. But now he's out. Goodman was brought in 19 months ago as the senior vice president in charge of Pfizer's California biotechnology center,
Pfizer's R&D shakeup based on bio-innovation
How does a pharma giant like Pfizer get entrepreneurial in the biotech field? For Corey Goodman, head of Pfizer's Biotherapeutics & Bioinnovations Center in San Francisco , the answer lies in
Pfizer launches regenerative medicine unit
Continuing its foray into the world of biotech, Pfizer announced today that it is launching Pfizer Regenerative Medicine, an independent research unit that will research and develop new medicines
Pfizer expands adult stem cell therapy work
Pfizer is steadily expanding its presence in the stem cell field. The Wall Street Journal notes that in November the pharma giant will open a regenerative medicine shop in Cambridge, England. It
Pfizer moves employees to San Francisco
In a major coup for San Francisco, Pfizer is moving 100 employees--along with the headquarters of its Biotherapeutics and Bioinnovation
